doi: 10.1016/j.femsle.2005.05.043 27 Pedras C.S
The epidemiological association between elevated IGF-1 and certain cancers applies, though ipamorelin's pulsatile (rather than continuous) GH elevation may produce a different risk profile than sustained GH or IGF-1 elevation
Combination protocols offer enhanced benefits but require sophisticated compounding capabilities
What people praise: meaningful weight loss, improved glucose control, reduced appetite, and increased motivation to maintain lifestyle changes
The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)